Oral etoposide as a single agent in childhood and young adult cancer in England: Still a poorly evaluated palliative treatment.

This report is the largest series to date of oral etoposide use in childhood and young adult cancer. Most patients treated in this real world setting died quickly. Despite decades of use, there are still no robust data demonstrating a clear benefit of oral etoposide for survival.